← Leaderboards
Pascal Poignard
Scripps Research Institute
$1,447,985
Attributed
$1,447,985
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,447,985 · 2
By mechanism
R01$1,434,261 · 1
M01$13,724 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Dennis R. Burton$354,198,604
- Erica Ollmann Saphire$52,684,297
- Michael B Oldstone$35,619,947
- Francis Vincent Chisari$28,451,545
- John H Elder$17,394,458
Others in their field
Top investigators on “Human Immunodeficiency Virus 1”
- Constance Ann Benson · University Of California, San Diego$122,634,267
- Barton F Haynes · Duke University$106,892,200
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$103,430,446
- George R Seage · Abt Associates, Inc.$96,260,237
- Dennis R. Burton · Scripps Research Institute$73,539,073
- Rama Rao Amara · Emory University$62,827,078
Research focus
Human Immunodeficiency Virus 1Virus Infection MechanismDisease /Disorder ModelNeutralizing AntibodyCell Cell InteractionLaboratory MouseMutantNonhuman Therapy EvaluationVirus ReplicationScid MouseHiv InfectionsHost Organism InteractionImmune ResponseInhibitor /AntagonistClinical Research
Grant awards (5)
Viral evasion and HIV entry-blocking strategies$13,724
M01 · FY2004 · RR
VIRAL EVASION AND HIV ENTRY-BLOCKING STRATEGIES$373,963
R01 · FY2003 · AI
VIRAL EVASION AND HIV ENTRY-BLOCKING STRATEGIES$363,071
R01 · FY2002 · AI
VIRAL EVASION AND HIV ENTRY-BLOCKING STRATEGIES$352,497
R01 · FY2001 · AI
VIRAL EVASION AND HIV ENTRY-BLOCKING STRATEGIES$344,730
R01 · FY2000 · AI